The concordance between the evolutionary trend and the clinical manifestation of the two SARS-CoV-2 variants
暂无分享,去创建一个
Ya-ping Zhang | Yirong Wang | Jian Lu | Yirong Li | Xuemei Lu | Ming Wang | Dong Men | Xiaolu Tang | Xinmin Yao | Hong Zhang | Lilei Yu | Liangjun Chen | Guangming Ye | Di Li | Tiangang Liu | Y. Tong | Aisi Fu | Zhiwei Feng | Bende Liu | Junping Yu | Ran Liu | Ben Hu | Yan Li | Zixin Deng | Gaigai Shen | Wanxu Zhao | Yuchen Pan | Ruochen Ying | Jing Peng | Jiefang Guo | Jingju Peng | Lilei Yu
[1] Weizhong Yang,et al. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study , 2021, The Lancet.
[2] Songnian Hu,et al. Evolutionary analysis and lineage designation of SARS-CoV-2 genomes , 2021, Science Bulletin.
[3] Carl A. B. Pearson,et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England , 2021, Science.
[4] D. A. Jackson,et al. Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity , 2020, Cell.
[5] Lanjuan Li,et al. Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo , 2020, Cell discovery.
[6] Edward C. Holmes,et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology , 2020, Nature Microbiology.
[7] Yirong Wang,et al. The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2 , 2020, Science China Life Sciences.
[8] S. Rowland-Jones,et al. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus , 2020, Cell.
[9] W. Wang,et al. Viral and host factors related to the clinical outcome of COVID-19 , 2020, Nature.
[10] Colin Renfrew,et al. Phylogenetic network analysis of SARS-CoV-2 genomes , 2020, Proceedings of the National Academy of Sciences.
[11] Xiang Li,et al. On the origin and continuing evolution of SARS-CoV-2 , 2020, National science review.
[12] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[13] E. Holmes,et al. A new coronavirus associated with human respiratory disease in China , 2020, Nature.
[14] M. Franzblau,et al. Conflict of Interest Statement , 2004 .